(2R,3S,4S,5R,6R)-2-((1S,2S)-2-Chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-3,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-4-yl dihydrogen phosphate

95%

Reagent Code: #229022
fingerprint
CAS Number 28708-34-1

science Other reagents with same CAS 28708-34-1

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 504.96 g/mol
Formula C₁₈H₃₄ClN₂O₈PS
badge Registry Numbers
MDL Number MFCD21363518
inventory_2 Storage & Handling
Storage 2-8°C, light-proof, inert gas

description Product Description

Used in pharmaceutical research as a key intermediate in the synthesis of novel antidiabetic agents, particularly in the development of SGLT2 inhibitors. Its structural features enable selective modulation of glucose reabsorption in the kidneys, making it valuable in creating drugs for type 2 diabetes. The chloro and methylthio groups enhance metabolic stability, while the phosphate moiety improves solubility and bioavailability during drug formulation. It is also explored in prodrug designs to optimize pharmacokinetic profiles.

Available Sizes & Pricing

Size Availability Unit Price Quantity
1mg
10-20 days ฿2,370.00
5mg
10-20 days ฿7,120.00
10mg
10-20 days ฿12,100.00
(2R,3S,4S,5R,6R)-2-((1S,2S)-2-Chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-3,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-4-yl dihydrogen phosphate
No image available

Used in pharmaceutical research as a key intermediate in the synthesis of novel antidiabetic agents, particularly in the development of SGLT2 inhibitors. Its structural features enable selective modulation of glucose reabsorption in the kidneys, making it valuable in creating drugs for type 2 diabetes. The chloro and methylthio groups enhance metabolic stability, while the phosphate moiety improves solubility and bioavailability during drug formulation. It is also explored in prodrug designs to optimize

Used in pharmaceutical research as a key intermediate in the synthesis of novel antidiabetic agents, particularly in the development of SGLT2 inhibitors. Its structural features enable selective modulation of glucose reabsorption in the kidneys, making it valuable in creating drugs for type 2 diabetes. The chloro and methylthio groups enhance metabolic stability, while the phosphate moiety improves solubility and bioavailability during drug formulation. It is also explored in prodrug designs to optimize pharmacokinetic profiles.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Recommended Dosage -
Dosage (Per Day) -
Recommended Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...